Sudubrilimab (HS636) is an Ig G1-kappa моноклональный антитело against PDL1. Sudubrilimab is fused at the C terminus of the heavy chain to a TGF-β1 рецептор Ⅱ ectodomain (TGFBR2-ECD), and which can sequester the PD-1/PD-L1 pathway and TGF-β bioactivity in the immunosuppressive tumor microenvironment.
Sudubrilimab (HS636) is an Ig G1-kappa monoclonal antibody against PDL1. Sudubrilimab is fused at the C terminus of the heavy chain to a TGF-β1 receptor Ⅱ ectodomain (TGFBR2-ECD), and which can sequester the PD-1/PD-L1 pathway and TGF-β bioactivity in the immunosuppressive tumor microenvironment.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.